CARDIOPHARMA ApS

CVR 13966273 · Private limited company (ApS) · Active · Low risk

CARDIOPHARMA ApS is a Private limited company (ApS), founded on , based in Gentofte. The company is registered in the industry virksomhedsrådgivning og anden ledelsesrådgivning. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 20 annual reports have been published. The latest annual report (30 Apr 2026) shows equity of DKK 31.6m and a net result of DKK 3.1m. CEO: Niels Christian Fischer Petersen.

Bankruptcy risk for CARDIOPHARMA ApS

0.0%
probability of bankruptcy within 12 months
Low risk

0.0 × the average (1.41%) · higher risk than 0% of active Danish companies

Lowest riskHighest risk

Increases the risk

Auditor's statementNo assurance · bankruptcy rate 13.2%1.5×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
CEO changes1 · bankruptcy rate 11.4%1.3×

Reduces the risk

Current ratio500%+ · bankruptcy rate 1.5%0.17×
Age (years)20+ yrs · bankruptcy rate 2.0%0.23×
Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Published annual reports10+ · bankruptcy rate 3.0%0.35×
Time at current address5+ yrs · bankruptcy rate 3.1%0.35×
Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Return on assets5%–15% · bankruptcy rate 3.5%0.39×
Number of auditors (historical)3+ · bankruptcy rate 3.7%0.42×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
13966273
Status
Active
Company type
Private limited company (ApS)
Founded
(36 years)
Address
Bregnevej 39
2820 Gentofte
Municipality
Gentofte
Industry
Virksomhedsrådgivning og anden ledelsesrådgivning (702000)
Bankruptcies in the industry: Virksomhedsrådgivning og anden rådgivning om driftsledelse
Share capital
DKK 125k
Auditor
Finn Ellgaard
Audit opted out
No

Warning signs

Annual reports filed late0 of 31
Missing annual reportNo
Negative equityNo
Equity ratio99.9%
Current ratio29,883%
Moves (last 2 years)0
CEO changes in total1
CEO's previous bankruptcies0
Other companies at the address0
Going-concern uncertaintyNo

Financials and key figures

Financial year202620252024
RevenueDKK 0DKK 0DKK 0
Gross profitDKK 4.3mDKK 2.7mDKK 2.6m
Net profitDKK 3.1mDKK 2.0mDKK 2.9m
EquityDKK 31.6mDKK 28.5mDKK 28.3m
Total assetsDKK 31.6mDKK 28.5mDKK 28.3m
CashDKK 2.7mDKK 1.7m–
Short-term debtDKK 40kDKK 30k–
Avg. employees00–

Latest annual report: Reporting class B · auditor's statement: No assurance.

Filed annual reports

Reporting periodPublishedDays after period end
1 May 2025 – 30 Apr 2026131
1 May 2024 – 30 Apr 2025168
1 May 2023 – 30 Apr 2024133
1 May 2022 – 30 Apr 2023135
1 May 2021 – 30 Apr 2022138
1 May 2020 – 30 Apr 2021111
1 May 2019 – 30 Apr 2020146
1 May 2018 – 30 Apr 2019114
1 May 2017 – 30 Apr 2018143
1 May 2016 – 30 Apr 2017131
1 May 2015 – 30 Apr 2016122
1 May 2014 – 30 Apr 2015124
1 May 2013 – 30 Apr 2014112
1 May 2012 – 30 Apr 2013122
1 May 2011 – 30 Apr 2012143
1 May 2010 – 30 Apr 2011137
1 May 2009 – 30 Apr 2010136
1 May 2008 – 30 Apr 2009151
1 May 2007 – 30 Apr 2008151
1 May 2006 – 30 Apr 2007153

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEONiels Christian Fischer PetersenCurrent
CEOHenrik Stenbjerre
Owner (100%)Niels Christian Fischer PetersenCurrent
AuditorFinn EllgaardCurrent
AuditorCJ Partnership I/S
AuditorErik Schwartz
FounderKR 332 ApSCurrent

The CEOs' other companies

Niels Christian Fischer Petersen – 8 other companies

Henrik Stenbjerre – 54 other companies, of which 27 bankrupt

Address history (0 moves)

Bregnevej 39, 2820 Gentofte

Former names

CARDIOPHARMA ApS – now
KM 455 ApS –

Similar companies in Gentofte

Questions and answers about CARDIOPHARMA ApS

Has CARDIOPHARMA ApS gone bankrupt?

No, CARDIOPHARMA ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of CARDIOPHARMA ApS?

Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.

Who is the CEO of CARDIOPHARMA ApS?

Niels Christian Fischer Petersen is the CEO of CARDIOPHARMA ApS.

Who is the auditor of CARDIOPHARMA ApS?

CARDIOPHARMA ApS most recently used Finn Ellgaard.

When was CARDIOPHARMA ApS founded?

CARDIOPHARMA ApS was founded on 9 January 1990.

What is the equity of CARDIOPHARMA ApS?

Equity was DKK 31.6m according to the annual report for the period ending 30 April 2026.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.